v3.26.1
Significant Accounting Policies - Schedule of Significant Revenue and Expense Categories (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting [Line Items]            
Total revenue $ 5,862   $ 12,702   $ 10,885 $ 16,141
Cost of product revenue 435   340   979 763
Cost of license and collaboration revenue 443   154   788 168
Selling, general and administrative 10,349   8,852   20,338 17,700
Research and development 6,034   1,846   9,894 4,130
Legal settlement, net of insurance recovery (1,698)   0   (1,698) 0
Other expense (56)   (1,306)   (23) (2,918)
Net (loss) income (13,153) $ (9,682) 204 $ (9,742) (22,835) (9,538)
Product revenue, net            
Segment Reporting [Line Items]            
Total revenue 5,093   4,534   9,383 7,956
License and collaboration revenue            
Segment Reporting [Line Items]            
Total revenue 769   8,168   1,502 8,185
Reportable Segment            
Segment Reporting [Line Items]            
Total revenue 5,862   12,702   10,885 16,141
Cost of product revenue 435   340   979 763
Cost of license and collaboration revenue 443   154   788 168
Selling, general and administrative 10,349   8,852   20,338 17,700
Research and development 6,034   1,846   9,894 4,130
Legal settlement, net of insurance recovery 1,698   0   1,698 0
Other expense 56   1,306   23 2,918
Net (loss) income (13,153)   204   (22,835) (9,538)
Reportable Segment | Commercial (including payroll)            
Segment Reporting [Line Items]            
Selling, general and administrative 5,676   4,346   11,373 8,628
Reportable Segment | General and administrative (including payroll)            
Segment Reporting [Line Items]            
Selling, general and administrative 3,874   3,918   7,573 7,699
Reportable Segment | Stock-based compensation            
Segment Reporting [Line Items]            
Selling, general and administrative 799   588   1,392 1,373
Research and development 396   300   672 541
Reportable Segment | Other unallocated expenses            
Segment Reporting [Line Items]            
Research and development 1,385   1,266   2,927 2,750
Reportable Segment | Product revenue, net            
Segment Reporting [Line Items]            
Total revenue 5,093   4,534   9,383 7,956
Reportable Segment | License and collaboration revenue            
Segment Reporting [Line Items]            
Total revenue 769   8,168   1,502 8,185
Reportable Segment | YCANTH (VP-102)            
Segment Reporting [Line Items]            
Research and development 808   340   1,086 711
Reportable Segment | VP-315            
Segment Reporting [Line Items]            
Research and development 68   33   201 194
Reportable Segment | Common warts            
Segment Reporting [Line Items]            
Research and development $ 3,377   $ (93)   $ 5,008 $ (66)